Cardiology

Even as 2nd-line drugs, sulfonylureas shown to be cardiotoxic with high rate of low blood glucose

Reducing HbA1c may be new goal of therapy to prevent coronary artery disease and other subtypes.

Getting diabetes in our later years increases risk for CVD, but getting diabetes or prediabetes as a youth increases risk for CVD and death dramatically.

Drug shown to reduce risk of CV death or hospitalization for heart failure in adults with CV disease and type 2 diabetes, irrespective of their CV risk at study start.

Discrepancies prompt additional analyses of ACCORD-BP and SPRINT studies to determine best blood pressure target for those with diabetes.

Elevated BP readings at the doctor’s office linked to higher mortality than for those with consistently normal blood pressure.

Pooled analysis from two randomized trials shows significant differences in effects on two groups.

Study looks at whether intensive BP lowering can increase the risk of CKD.

High blood pressure and prediabetes together may do more harm to the body than either one alone.

Medication use may be associated with increased risk of mortality.